Northwest Biotherapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2012 | $12.6M | $7.6M | $7.3M |
| FY2013 | $19.7M | $18.8M | $18.5M |
| FY2014 | $91.5M | $56.5M | $13.4M |
| FY2015 | $75.5M | $70.8M | $21.8M |
| FY2016 | $79.4M | $52.9M | $6.9M |
| FY2017 | $96.2M | $48.9M | $117.0K |
| FY2018 | $71.8M | $24.7M | $22.2M |
| FY2019 | $55.7M | $10.6M | $372.0K |
| FY2020 | $395.8M | $32.9M | $10.0M |
| FY2021 | $164.2M | $40.2M | $15.2M |